SCHEDULE 13G

Company

Tvardi Therapeutics, Inc.

Filed

April 20, 2015

Accession Number

0000932440-15-000133

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →